BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Margolis DJA, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. Molecular Imaging Techniques in Body Imaging. Radiology 2007;245:333-56. [DOI: 10.1148/radiol.2452061117] [Cited by in Crossref: 92] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 de la Encarnación C, Jimenez de Aberasturi D, Liz-marzán LM. Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114484] [Reference Citation Analysis]
2 Park H, Yi M, Lee JS. Silicon photomultiplier signal readout and multiplexing techniques for positron emission tomography: a review. Biomed Eng Lett . [DOI: 10.1007/s13534-022-00234-y] [Reference Citation Analysis]
3 La Fontaine MD, Bruin NM, van Kranen S, Knegjens JL, van de Kamer JB, Vogel WV, Sonke JJ. The dynamics and prognostic value of FDG PET-metrics in weekly monitoring of (chemo)radiotherapy for NSCLC. Radiother Oncol 2021;160:107-14. [PMID: 33872642 DOI: 10.1016/j.radonc.2021.04.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang Y, Zhang C, Lai J, Zhao Y, Lu D, Bao R, Feng X, Zhang T, Liu Z. Noninvasive PET tracking of post-transplant gut microbiota in living mice. Eur J Nucl Med Mol Imaging 2020;47:991-1002. [DOI: 10.1007/s00259-019-04639-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Yim MS, Son EJ, Kim HN, Ryu EK. A TAT-conjugated peptide inhibitor of polo-like kinase 1 for in vivo tumor imaging. J Anal Sci Technol 2019;10. [DOI: 10.1186/s40543-019-0187-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 He X, Luo Q, Zhang J, Chen P, Wang H, Luo K, Yu X. Gadolinium-doped carbon dots as nano-theranostic agents for MR/FL diagnosis and gene delivery. Nanoscale 2019;11:12973-82. [DOI: 10.1039/c9nr03988k] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
7 Chen H, Gu Z, An H, Chen C, Chen J, Cui R, Chen S, Chen W, Chen X, Chen X, Chen Z, Ding B, Dong Q, Fan Q, Fu T, Hou D, Jiang Q, Ke H, Jiang X, Liu G, Li S, Li T, Liu Z, Nie G, Ovais M, Pang D, Qiu N, Shen Y, Tian H, Wang C, Wang H, Wang Z, Xu H, Xu J, Yang X, Zhu S, Zheng X, Zhang X, Zhao Y, Tan W, Zhang X, Zhao Y. Precise nanomedicine for intelligent therapy of cancer. Sci China Chem 2018;61:1503-52. [DOI: 10.1007/s11426-018-9397-5] [Cited by in Crossref: 215] [Cited by in F6Publishing: 227] [Article Influence: 53.8] [Reference Citation Analysis]
8 Elshafey R, Daabes N, Galal S. FDG-PET/CT in re-staging of patients with non Hodgkin lymphoma and monitory response to therapy in Egypt. The Egyptian Journal of Radiology and Nuclear Medicine 2018;49:1076-82. [DOI: 10.1016/j.ejrnm.2018.06.003] [Reference Citation Analysis]
9 Perrin DM. Organotrifluoroborates as prosthetic groups for Single-Step F18-Labeling of Complex Molecules. Current Opinion in Chemical Biology 2018;45:86-94. [DOI: 10.1016/j.cbpa.2018.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang C, Yu X, Gao L, Zhao Y, Lai J, Lu D, Bao R, Jia B, Zhong L, Wang F, Liu Z. Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis. Theranostics 2017;7:4276-88. [PMID: 29158825 DOI: 10.7150/thno.20999] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]
11 El-Haddad G. PET-Based Percutaneous Needle Biopsy. PET Clin 2016;11:333-49. [PMID: 27321036 DOI: 10.1016/j.cpet.2016.02.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
12 Baum RP, Kulkarni HR, Müller D, Satz S, Danthi N, Kim YS, Brechbiel MW. First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting. Cancer Biother Radiopharm 2015;30:152-9. [PMID: 25945808 DOI: 10.1089/cbr.2014.1747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
13 Satapathy R, Dash BP, Mahanta CS, Swain BR, Jena BB, Hosmane NS. Glycoconjugates of polyhedral boron clusters. Journal of Organometallic Chemistry 2015;798:13-23. [DOI: 10.1016/j.jorganchem.2015.06.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
14 Alam SR, Stirrat C, Richards J, Mirsadraee S, Semple SI, Tse G, Henriksen P, Newby DE. Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide. J Cardiovasc Magn Reson 2015;17:83. [PMID: 26381872 DOI: 10.1186/s12968-015-0183-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kang WJ, Lee J, Lee YS, Cho S, Ali BA, Al-Khedhairy AA, Heo H, Kim S. Multimodal imaging probe for targeting cancer cells using uMUC-1 aptamer. Colloids Surf B Biointerfaces 2015;136:134-40. [PMID: 26387066 DOI: 10.1016/j.colsurfb.2015.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
16 Edelman RR. The history of MR imaging as seen through the pages of radiology. Radiology 2014;273:S181-200. [PMID: 25340436 DOI: 10.1148/radiol.14140706] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
17 Shirshahi V, Soltani M. Solid silica nanoparticles: applications in molecular imaging. Contrast Media Mol Imaging 2015;10:1-17. [PMID: 24996058 DOI: 10.1002/cmmi.1611] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
18 Brand C, Abdel-Atti D, Zhang Y, Carlin S, Clardy SM, Keliher EJ, Weber WA, Lewis JS, Reiner T. In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent. Bioconjug Chem 2014;25:1323-30. [PMID: 24856928 DOI: 10.1021/bc500178d] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
19 Xue S, Wang Y, Wang M, Zhang L, Du X, Gu H, Zhang C. Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging. Int J Nanomedicine 2014;9:2527-38. [PMID: 24904212 DOI: 10.2147/IJN.S59754] [Cited by in Crossref: 14] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
20 Nofiele JT, Haedicke IE, Zhu Yle K, Zhang XA, Cheng HL. Gadolinium-free extracellular MR contrast agent for tumor imaging. J Magn Reson Imaging 2015;41:397-403. [PMID: 24399613 DOI: 10.1002/jmri.24561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
21 Wei X, Wang W, Chen K. ZnO:Er,Yb,Gd Particles Designed for Magnetic-Fluorescent Imaging and Near-Infrared Light Triggered Photodynamic Therapy. J Phys Chem C 2013;117:23716-29. [DOI: 10.1021/jp4071696] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kwee TC, Torigian DA, Alavi A. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification. J Thorac Imaging 2013;28:4-10. [PMID: 23249967 DOI: 10.1097/RTI.0b013e31827882d9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
23 Wolters M, Mohades SG, Hackeng TM, Post MJ, Kooi ME, Backes WH. Clinical Perspectives of Hybrid Proton-Fluorine Magnetic Resonance Imaging and Spectroscopy: . Investigative Radiology 2013;48:341-50. [DOI: 10.1097/rli.0b013e318277528c] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
24 Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol 2012;14:718-24. [PMID: 22476968 DOI: 10.1007/s11307-012-0557-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
25 Liu S, Lin TP, Li D, Leamer L, Shan H, Li Z, Gabbaï FP, Conti PS. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics 2013;3:181-9. [PMID: 23471211 DOI: 10.7150/thno.5984] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
26 Kwee TC, Torigian DA, Alavi A. Oncological Applications of Positron Emission Tomography for Evaluation of the Thorax. Journal of Thoracic Imaging 2013;28:11-24. [DOI: 10.1097/rti.0b013e318279449b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
27 Kwee TC, Torigian DA, Alavi A. Nononcological Applications of Positron Emission Tomography for Evaluation of the Thorax. Journal of Thoracic Imaging 2013;28:25-39. [DOI: 10.1097/rti.0b013e31827882a9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
28 Nasimi P, Haidari M. Medical Use of Nanoparticles: Drug Delivery and Diagnosis Diseases. International Journal of Green Nanotechnology 2013;1:194308921350697. [DOI: 10.1177/1943089213506978] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
29 Sonmez AE, Webb AG, Spees WM, Ozcan A, Tsekos NV. A system for endoscopic mechanically scanned localized proton MR and light-induced fluorescence emission spectroscopies. Journal of Magnetic Resonance 2012;222:16-25. [DOI: 10.1016/j.jmr.2012.06.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 2012;39:1659-65. [PMID: 22753657 DOI: 10.3899/jrheum.111597] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
31 Skotland T. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use. Contrast Media Mol Imaging. 2012;7:1-6. [PMID: 22344874 DOI: 10.1002/cmmi.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
32 Li S, Goins B, Zhang L, Bao A. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug Chem 2012;23:1322-32. [PMID: 22577859 DOI: 10.1021/bc300175d] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 10.7] [Reference Citation Analysis]
33 Luchetti A, Milani D, Ruffini F, Galli R, Falini A, Quattrini A, Scotti G, Comi G, Martino G, Furlan R, Politi LS. Monoclonal Antibodies Conjugated with Superparamagnetic Iron Oxide Particles Allow Magnetic Resonance Imaging Detection of Lymphocytes in the Mouse Brain. Mol Imaging 2012;11:7290.2011.00032. [DOI: 10.2310/7290.2011.00032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
34 Gao M, Wang M, Miller KD, Zheng QH. Facile radiosynthesis of new carbon-11-labeled propanamide derivatives as selective androgen receptor modulator (SARM) radioligands for prostate cancer imaging. Steroids 2011;76:1505-12. [PMID: 21867721 DOI: 10.1016/j.steroids.2011.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
35 Cottone L, Valtorta S, Capobianco A, Belloli S, Rovere-querini P, Fazio F, Manfredi AA, Moresco RM. Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18 F-FDG PET. J Nucl Med 2011;52:1770-7. [DOI: 10.2967/jnumed.111.089177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Sukerkar PA, MacRenaris KW, Meade TJ, Burdette JE. A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo. Mol Pharm 2011;8:1390-400. [PMID: 21736390 DOI: 10.1021/mp200219e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
37 Maia S, Ayachi Hatit N, Paycha F. [Situation of supply and boom of PET imaging: what is the future for technetium-99m in nuclear medicine?]. Ann Pharm Fr 2011;69:155-64. [PMID: 21570540 DOI: 10.1016/j.pharma.2011.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Werner MK, Aschoff P, Reimold M, Pfannenberg C. FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies. Br J Radiol 2011;84:e65-7. [PMID: 21325361 DOI: 10.1259/bjr/26998246] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
39 Konieva AA, Kholodenko IV, Shragina OA, Kholodenko RV, Burunova VV, Bibaeva LV, Yarygin KN, Yarygin VN. Functional properties of mesenchymal stem cells labeled with magnetic microparticles in vitro and analysis of their distribution after transplantation. Bull Exp Biol Med 2010;150:131-6. [PMID: 21161071 DOI: 10.1007/s10517-010-1087-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
40 Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010;65:500-516. [PMID: 20541650 DOI: 10.1016/j.crad.2010.03.011] [Cited by in Crossref: 334] [Cited by in F6Publishing: 317] [Article Influence: 27.8] [Reference Citation Analysis]
41 Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ. Combined PET/MRI: one step further in multimodality imaging. Trends Mol Med 2010;16:508-15. [PMID: 20851684 DOI: 10.1016/j.molmed.2010.08.003] [Cited by in Crossref: 97] [Cited by in F6Publishing: 72] [Article Influence: 8.1] [Reference Citation Analysis]
42 Okada M, Sato N, Ishii K, Matsumura K, Hosono M, Murakami T. FDG PET/CT versus CT, MR Imaging, and 67 Ga Scintigraphy in the Posttherapy Evaluation of Malignant Lymphoma . RadioGraphics 2010;30:939-57. [DOI: 10.1148/rg.304095150] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
43 Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C. High-grade endometrial cancer: value of [18F]FDG PET/CT in preoperative staging. Nuclear Medicine Communications 2010;31:506-12. [DOI: 10.1097/mnm.0b013e328337cb47] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
44 Laing RE, Nair-Gill E, Witte ON, Radu CG. Visualizing cancer and immune cell function with metabolic positron emission tomography. Curr Opin Genet Dev 2010;20:100-5. [PMID: 19931447 DOI: 10.1016/j.gde.2009.10.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
45 Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis. Mol Membr Biol 2010;27:274-85. [PMID: 20455640 DOI: 10.3109/09687688.2010.481640] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
46 Tozaki M, Hoshi K. 1H MR Spectroscopy of Invasive Ductal Carcinoma: Correlations With FDG PET and Histologic Prognostic Factors. American Journal of Roentgenology 2010;194:1384-90. [DOI: 10.2214/ajr.09.3431] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
47 Morse DL, Gillies RJ. Molecular imaging and targeted therapies. Biochem Pharmacol 2010;80:731-8. [PMID: 20399197 DOI: 10.1016/j.bcp.2010.04.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
48 Wyatt SK, Manning HC, Bai M, Bailey SN, Gallant P, Ma G, McIntosh L, Bornhop DJ. Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer. Mol Imaging Biol 2010;12:349-58. [PMID: 19949989 DOI: 10.1007/s11307-009-0270-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
49 Gallagher FA, Kettunen MI, Hu DE, Jensen PR, Zandt RI, Karlsson M, Gisselsson A, Nelson SK, Witney TH, Bohndiek SE, Hansson G, Peitersen T, Lerche MH, Brindle KM. Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A 2009;106:19801-6. [PMID: 19903889 DOI: 10.1073/pnas.0911447106] [Cited by in Crossref: 219] [Cited by in F6Publishing: 200] [Article Influence: 16.8] [Reference Citation Analysis]
50 Sroka IC, Pond GD, Nagle RB, Porreca F, King T, Pestano G, Futscher BW, Gard JM, Riley J, Cress AE. Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. Open Prost Cancer J 2009;2:59-66. [PMID: 22081777 DOI: 10.2174/1876822900902010059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
51 Benoit MR, Mayer D, Barak Y, Chen IY, Hu W, Cheng Z, Wang SX, Spielman DM, Gambhir SS, Matin A. Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Cancer Res 2009;15:5170-7. [PMID: 19671860 DOI: 10.1158/1078-0432.CCR-08-3206] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
52 Gee MS, Harisinghani MG, Tabatabaei S. Molecular Imaging in Urologic Surgery. Urologic Clinics of North America 2009;36:125-32. [DOI: 10.1016/j.ucl.2009.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Belloli S, Jachetti E, Moresco RM, Picchio M, Lecchi M, Valtorta S, Freschi M, Hess Michelini R, Bellone M, Fazio F. Characterization of preclinical models of prostate cancer using PET-based molecular imaging. Eur J Nucl Med Mol Imaging 2009;36:1245-55. [PMID: 19280188 DOI: 10.1007/s00259-009-1091-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, Blasberg RG, Fong Y, Gil Z. Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. PLoS One 2009;4:e4789. [PMID: 19274083 DOI: 10.1371/journal.pone.0004789] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
55 Klaeser B, Mueller MD, Schmid RA, Guevara C, Krause T, Wiskirchen J. PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences. Eur Radiol 2009;19:1780-5. [DOI: 10.1007/s00330-009-1338-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
56 Harolds JA, Smith GT, Baker SR. Trends and different educational pathways for training physicians in nuclear medicine. Acad Radiol 2008;15:1596-603. [PMID: 19000877 DOI: 10.1016/j.acra.2008.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
57 De M, Ghosh PS, Rotello VM. Applications of Nanoparticles in Biology. Adv Mater 2008;20:4225-41. [DOI: 10.1002/adma.200703183] [Cited by in Crossref: 1205] [Cited by in F6Publishing: 891] [Article Influence: 86.1] [Reference Citation Analysis]
58 Hyodo F, Soule BP, Matsumoto K, Matusmoto S, Cook JA, Hyodo E, Sowers AL, Krishna MC, Mitchell JB. Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging. J Pharm Pharmacol 2008;60:1049-60. [PMID: 18644197 DOI: 10.1211/jpp.60.8.0011] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
59 Green AE, Harrington LE, Valliant JF. Carborane-carbohydrate derivatives — Versatile platforms for developing targeted radiopharmaceuticals. Can J Chem 2008;86:1063-9. [DOI: 10.1139/v08-157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
60 Spencer J. Indeterminate lesions in cancer imaging. Clinical Radiology 2008;63:843-52. [DOI: 10.1016/j.crad.2007.11.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Hoeffel C, Mulé S, Romaniuk B, Ladam-Marcus V, Bouché O, Marcus C. Advances in radiological imaging of gastrointestinal tumors. Crit Rev Oncol Hematol. 2009;69:153-167. [PMID: 18674926 DOI: 10.1016/j.critrevonc.2008.06.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
62 Buijs M, Vossen JA, Geschwind JF, Ishimori T, Engles JM, Acha-Ngwodo O, Wahl RL, Vali M. Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer. Invest New Drugs 2009;27:120-3. [PMID: 18553054 DOI: 10.1007/s10637-008-9145-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
63 Griffiths GL. The imaging probe development center and the production of molecular imaging probes. Curr Chem Genomics 2008;1:65-9. [PMID: 20161829 DOI: 10.2174/1875397300801010065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Vandecaveye V, De Keyzer F, Dymarkowski S. Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors. Targ Oncol 2008;3:101-10. [DOI: 10.1007/s11523-008-0076-7] [Reference Citation Analysis]
65 Edelhauser G, Funovics M. Breast Cancer Treatment in the Era of Molecular Imaging. Breast Care (Basel) 2008;3:409-14. [PMID: 21048912 DOI: 10.1159/000181160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]